Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Cash Flow Reinvestment Rate
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥105.16 Million (capex CN¥105.16 Million ) from operating cash flow of CN¥504.02 Million. See 002773 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Chengdu Kanghong Pharmaceuticals Group C.
Annual Cash Flow Reinvestment Rate for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Chengdu Kanghong Pharmaceuticals Group Co Ltd. See 002773 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | CN¥299.36 Million | CN¥1.50 Billion | CN¥262.48 Million | ▲ +35.7% |
| 2024 | 0.15x | CN¥207.10 Million | CN¥1.41 Billion | CN¥159.39 Million | ▲ +22.8% |
| 2023 | 0.12x | CN¥145.49 Million | CN¥1.22 Billion | CN¥138.87 Million | ▼ -80.6% |
| 2022 | 0.62x | CN¥570.76 Million | CN¥925.15 Million | CN¥355.21 Million | ▼ -62.9% |
| 2021 | 1.66x | CN¥821.27 Million | CN¥494.11 Million | CN¥569.42 Million | ▼ -27.6% |
| 2020 | 2.29x | CN¥627.07 Million | CN¥273.32 Million | CN¥617.07 Million | ▲ +66.5% |
| 2019 | 1.38x | CN¥1.12 Billion | CN¥812.15 Million | CN¥962.88 Million | ▼ -28.9% |
| 2018 | 1.94x | CN¥680.45 Million | CN¥350.88 Million | CN¥458.45 Million | ▲ +159.6% |
| 2017 | 0.75x | CN¥572.88 Million | CN¥766.86 Million | CN¥312.88 Million | ▲ +50.4% |
| 2016 | 0.50x | CN¥420.39 Million | CN¥846.35 Million | CN¥170.23 Million | ▼ -16.9% |
| 2015 | 0.60x | CN¥288.04 Million | CN¥481.97 Million | CN¥115.83 Million | ▲ +92.9% |
| 2014 | 0.31x | CN¥90.27 Million | CN¥291.38 Million | CN¥90.27 Million | ▲ +33.8% |
| 2013 | 0.23x | CN¥77.16 Million | CN¥333.31 Million | CN¥77.16 Million | ▼ -49.6% |
| 2012 | 0.46x | CN¥129.51 Million | CN¥281.84 Million | CN¥129.51 Million | ▼ -50.7% |
| 2011 | 0.93x | CN¥157.25 Million | CN¥168.86 Million | CN¥157.25 Million | ▼ -3.3% |
| 2010 | 0.96x | CN¥131.76 Million | CN¥136.79 Million | CN¥131.76 Million | ▼ -34.0% |
| 2009 | 1.46x | CN¥158.27 Million | CN¥108.42 Million | CN¥158.27 Million | — |